Weiss Amir
SEC CIK 1897057 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | CAO | 13.1K | — | $2.30M | 21 | 2022-02-28 | 2026-08-21 |
Most active insiders at TEVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Francis Richard D | Pres, CEO | — | $31.26M |
| 2 | MIGNONE ROBERTO | Dir | — | $22.82M |
| 3 | Kalif Eliyahu Sharon | EVP, CFO | — | $20.72M |
| 4 | Sabag Mark | See "Remarks" | — | $13.15M |
| 5 | Daniell Richard | EVP, European Commercial | — | $12.08M |
| 6 | Hughes Eric A | See "Remarks" | — | $4.17M |
| 7 | Fox Christine | EVP, U.S. Commercial | — | $2.75M |
| 8 | Lippman Evan | EVP, Business Development | — | $2.16M |
| 9 | Weiss Amir | CAO | — | $1.41M |
| 10 | Shields Matthew | EVP, Gbl Ops | — | $1.40M |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-08-25 16:05 | 2026-08-21 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | S - Sale+OE | $37.62 | -9,445 | 13.1K | -42% | -$355.3K |
| D | 2026-08-25 16:05 | 2026-08-21 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | $19.61 | +2,500 | 15.6K | +19% | +$49.0K |
| 2026-05-07 16:03 | 2026-05-06 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | S - Sale | $36.00 | -10.7K | 20.0K | -35% | -$384.4K | |
| D | 2026-03-09 | 2026-03-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +3,537 | 30.7K | +13% | — |
| DM | 2026-03-06 | 2026-03-04 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +16.3K | 21.5K | +315% | — |
| D | 2026-03-05 | 2026-03-03 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +5,179 | 10.8K | +92% | — |
| 2025-12-18 | 2025-12-16 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | S - Sale | $30.20 | -12.3K | 5,650 | -69% | -$371.5K | |
| 2025-11-10 | 2025-11-06 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | S - Sale | $24.44 | -12.3K | 17.9K | -41% | -$300.6K | |
| D | 2025-03-07 | 2025-03-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +3,566 | 30.2K | +13% | — |
| DM | 2025-03-06 | 2025-03-04 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +16.3K | 26.7K | +158% | — |
| D | 2025-03-05 | 2025-03-03 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +5,179 | 10.4K | +100% | — |
| M | 2024-05-17 | 2024-05-15+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | S - Sale | $16.73 | -28.1K | 5,179 | -84% | -$470.8K |
| D | 2024-03-07 | 2024-03-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +3,564 | 33.3K | +12% | — |
| DM | 2024-03-05 | 2024-03-03+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +15.9K | 19.1K | +493% | — |
| D | 2024-03-01 | 2024-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +3,219 | 13.9K | +30% | — |
| 2024-02-05 | 2024-02-01 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | S - Sale | $12.37 | -31.8K | 10.7K | -75% | -$392.9K | |
| 2023-08-07 | 2023-08-04 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | S - Sale | $9.92 | -1,981 | 42.4K | -4% | -$19.7K | |
| DM | 2023-03-07 | 2023-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +16.6K | 41.2K | +68% | — |
| D | 2023-03-02 | 2023-02-28 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +3,219 | 27.8K | +13% | — |
| DM | 2022-03-08 | 2022-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +5,967 | 24.6K | +32% | — |
| DM | 2022-03-02 | 2022-02-28+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Weiss Amir | CAO | M - OptEx | — | +4,200 | 18.6K | +29% | — |
Purchase Sale Sale after option exercise All abbreviations